next generation glp 1 drugs GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness What is the pipeline for

Description

Before the company applied to the FDA for the drug to be approved for obesity, Knudsen and her colleagues 'developed a new methodology to show how [GLP-1] drugs exert their effect on the brain by working on the circumventricular organs and communicating further into the hypothalamus, among other effects.' This was designed to illustrate how GLP-1 worked in 'well- defined neurons in the hypothalamus, in the hindbrain, and in the reward centers.' Their rationale for developing the method was because 'It was very important to show that these medicines work on defined brain circuits and not ones that may be related to psychiatric or cardiovascular side effects, for example' (Nair

M., Pham, P

A robust pipeline of entero-pancreatic hormone-based therapies is currently in development, with several dual and triple agonists expected to emerge for obesity in the coming years

Another characteristic of study design that might confound comparisons between different agents is the temporal difference in excluding patients in the early post-MI period